• Harvard Diabetes Update 2024

Harvard Diabetes Update 2024

Harvard Diabetes Update 2024

$75.00 USD
$75.00 USD
SAVE Liquid error (snippets/price line 116): Computation results in '-Infinity'% Sold out
Harvard Diabetes Update 2024

Harvard Diabetes Update 2024

$75.00
$75.00
SAVE Liquid error (snippets/price line 116): Computation results in '-Infinity'% Sold out

  • Share positive thoughts and feedback from your customer.

    Author

  • Share positive thoughts and feedback from your customer.

    Author

  • Share positive thoughts and feedback from your customer.

    Author
    View full details

    The Harvard Medical School Diabetes Update



     

    EDUCATION to MEET THE CHALLENGES of DIABETES CARE

    Harvard Diabetes Update 2024 At a time when our diabetes knowledge and treatment options have advanced so much, why do clinical outcomes remain suboptimal, with so many patients unable to achieve good control of their disease?

    The answer is rooted in four challenges:
    • Keeping pace with rapidly advancing clinical options for diabetes care:
      • Therapies
      • Technologies
      • Lifestyle medicine interventions
    • Designing comprehensive therapeutic interventions based on frequent diabetes-associated diseases and complications
    • Accounting for a patient’s unique biological, psychological, social, financial, educational, and cultural factors
    • Overcoming structural healthcare barriers that require clinical strategies to fit within a particular mold

    This course is designed to equip clinicians to meet these challenges, providing practical, evidence-based approaches to optimize care for your patients.

    STRATEGIES, UPDATES, and BEST PRACTICES for STATE-OF-THE-ART DIABETES CARE

    This program affords you the opportunity to learn from leaders in the field of diabetes who are distinguished for their outstanding teaching, knowledge, and innovations in clinical care.

    Participants can rely on this program for comprehensive education to ensure state-of-the-art treatment. Coverage includes:
    • Design of more effective treatment plans
    • Current anti-diabetes medications and how to use them
    • Diagnosis of different types of diabetes
    • Utilization of recent technology advances in diabetes care
    • Optimizing care for people with obesity
    • Assessing and treating cardiovascular and renal complications
    • Guiding patients on physical activity and medical nutrition
    • Management of hypertension and dyslipidemia
    • Addressing low engagement in therapy
    NEW DATA and PRACTICE GUIDELINES for DIABETES CARE
    • The newest data on the identification of different types of diabetes
    • The latest scientific information on how to reduce cardiovascular and renal disease risk in patients with type 2 diabetes
    • New guidelines and practice recommendations for nutrition and physical activity coupled with instruction to incorporate them into your current approaches to diabetes care
    • Criteria to navigate the controversial data related to some anti-diabetes medications
    • Medical vs. surgical management of obesity
    • New technologies in diabetes care: updates and implications for day-to-day care
    • Research breakthroughs
    • Tips and tricks for navigating barriers within healthcare systems
    ASSESSMENT and TREATMENT of COMPLICATIONS from DIABETES

    The 2024 program provides education to assess and treat:
    • Cardiovascular Disease
    • Congestive Heart Failure
    • Renal Disease
    • Metabolic-Associated Fatty Liver Disease
    OPTIMIZING HEALTH OUTCOMES for DIVERSE PATIENT POPULATIONS

    This program also provides comprehensive guidance to account for biological, psychological, emotional, social, financial, and cultural factors that impact the development and progression of diabetes.

    Coverage includes:
    • Racial and ethnic minorities
    • The elderly
    • People with obesity
    • Patients at high cardiovascular risk
    • Individuals with low engagement in therapy
    • Patients at low socio-economic levels
    • Subjects with low health literacy/education
    • Individuals with depression/emotional distress
    • Patients with metabolic liver disease
    PRACTICE IMPACT

    Over four days, you will gain new, encompassing, evidence-based approaches to address the challenges seen in most clinical practices. More importantly, you will leave with knowledge—part art, part science—to make a real difference in the lives of your patients.


    Syllabus

    Schedule

    • Print

    Wednesday, May 1, 2024

    • 9:00am to 9:15am
    • Welcome and Introduction
    •  A. Enrique Caballero, MD

    Identifying Various Types of Diabetes in Clinical Practice

    • 9:15am to 9:40am
    • Is It Type 1 Diabetes, Type 2 Diabetes, or Something Else?
    • Miriam Udler, MD, PhD
    • 9:40am to 10:05am
    • Are All Pathophysiological Abnormalities in Patients with Type 2 Diabetes the Same?
    • Osama Hamdy, MD, PhD
    • 10:05am to 10:45am
    • Q and A and Practical Recommendations
    • Miriam Udler, MD, PhD and Osama Hamdy, MD, PhD
    • 10:45am to 11:00am
    • Break

    Medical Nutrition Management in Diabetes and Obesity

    • 11:00am to 11:25am
    • Pros and Cons of Most Popular Diets
    • Moe Schlachter, MS, RD, LD, CDCES
    • 11:25am to 11:50am
    • Current Dietary Recommendations in Diabetes and Obesity
    • Laura Andromalos, MS, RD, RN, CSOWM, CDCES
    • 11:50am to 12:30pm
    • Q and A and Practical Recommendations
    • Laura Andromalos, MS, RD, RN, CSOWM, CDCES and Moe Schlachter, MS, RD, LD, CDCES
    • 12:30pm to 1:20pm
    • Break

    Prescribing Exercise to Patients with Diabetes

    • 1:20pm to 1:45pm
    • Exercise Recommendations in Type 2 Diabetes and Obesity
    • Roeland J.W. Middelbeek, MD
    • 1:45pm to 2:10pm
    • A Practical Exercise Session Demonstration
    • Jacqueline I. Shahar, MEd, RCEP, CDCES
    • 2:10pm to 2:50pm
    • Q and A and Practical Recommendations
    • Roeland J.W. Middelbeek, MD and Jacqueline I. Shahar, MEd, RCEP, CDCES
    • 2:50pm to 3:00pm
    • Break

    Special Lecture

    • 3:00pm to 3:45pm
    • Improving Diabetes Care for All: A Daunting but Crucial Task in Clinical Practice
    • A. Enrique Caballero, MD

    Thursday, May 2, 2024

    • 9:00am to 9:10am
    • Welcome, Recap, and Introduction to Day 2

    Obesity Management in the Patient with Diabetes

    • 9:10am to 9:40am
    • Pharmacological Management: Individualizing Therapy
    • W. Scott Butsch, MD, MSc
    • 9:40am to 10:05am
    • Surgical Management: What Intervention and When?
    • Philip R. Schauer, MD
    • 10:05am to 10:45am
    • Q and A and Practical Recommendations
    • W. Scott Butsch, MD, MSc and Philip R. Schauer, MD
    • 10:45am to 11:00am
    • Break

    Dyslipidemia Management in Diabetes

    • 11:00am to 11:25am
    • Strategies to Achieve LDL-Cholesterol Goals in the Patient with Diabetes
    • Om P. Ganda, MD
    • 11:25am to 11:50am
    • What’s Next after Achieving LDL-Cholesterol Targets? An Update
    • Janet Lo, MD, MMSc
    • 11:50am to 12:30pm
    • Q and A and Practical Recommendations
    • Om P. Ganda, MD and Janet Lo, MD, MMSc
    • 12:30pm to 1:20pm
    • Break

    Hypertension Management in the Patient with Diabetes

    • 1:20pm to 1:45pm
    • Clinical Evaluation of the Patient with Hypertension and DiabetesAnand Vaidya, MD, MMSc
    • 1:45pm to 2:10pm
    • Strategies to Achieve Blood Pressure Targets
    • John P. Forman, MD, MSc
    • 2:10pm to 2:50pm
    • Q and A and Practical Recommendations
    • Anand Vaidya, MD, MMSc and John P. Forman, MD, MSc
    • 2:50pm to 3:00pm
    • Break

    Special Lecture

    3:00pm to 3:45pm
    Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD): A 2024 Vision


    Nezam Afdhal, MD

    Friday, May 3, 2024

    9:00am to 9:10am
    Welcome, Recap, and Introduction to Day 3

    Technology Advances in Diabetes Care

    9:10am to 9:40am
    Continuous Glucose Monitoring: A 2024 Vision


    Devin Steenkamp, MD

    9:40am to 10:05am
    Insulin Pumps, Closing the Loop: Where Do We Stand?


    Diana Isaacs, PharmD, BCPS, BCACP, BC-ADM, CDCES, FADCES, FCCP

    10:05am to 10:45am
    Q and A and Practical Recommendations


    Devin Steenkamp, MD and Diana Isaacs, PharmD, BCPS, BCACP, BC-ADM, CDCES, FADCES, FCCP

    10:45am to 11:00am
    Break

    Management of Diabetes in the Elderly Population

    • 11:00am to 11:25am
    • Type 2 Diabetes in the Elderly: Key Special Considerations
    • Marie E. McDonnell, MD
    • 11:25am to 11:50am
    • Selection, Intensification, and Deintensification of Pharmacological Therapies
    • Medha Munshi, MD
    • 11:50am to 12:30pm
    • Q and A and Practical Recommendations
    • Marie E. McDonnell, MD and Medha Munshi, MD
    • 12:30pm to 1:20pm
    • Break

    Addressing Diversity in Diabetes Care

    • 1:20pm to 1:45pm
    • The Impact of Personal, Social, Financial, and Cultural Factors in Diabetes Care
    • Rocio Pereira, MD
    • 1:45pm to 2:10pm

    Practical Strategies to Address Social Determinants of Health in Clinical Practice

    • A. Enrique Caballero, MD
    • 2:10pm to 2:50pm
    • Q and A and Practical Recommendations
    • Rocio Pereira, MD and A. Enrique Caballero, MD
    • 2:50pm to 3:00pm
    • Break

    Special Lecture

    • 3:00pm to 3:45pm
    • Emotional Distress and Psychological Factors in the Patient with Diabetes
    • Mary deGroot, PhD

    Saturday, May 4, 2024

    • 9:00am to 9:10am
    • Welcome, Recap, and Introduction to Day 4

    Evaluation of Cardiovascular and Renal Status and Risk in Diabetes Care

    • 9:10am to 9:40am
    • CV Disease in the Patient with Diabetes: Practical Assessment
    • Jorge Plutzky, MD
    • 9:40am to 10:10am
    • Evaluation of Renal Function Status and Risk in Diabetes
    • Robert Stanton, MD
    • 10:10am to 10:50am
    • Q and A and Practical Recommendations
    • Jorge Plutzky, MD and Robert Stanton, MD
    • 10:50am to 11:05am
    • Break

    Pharmacological Management of Type 2 Diabetes: Traditional Medications

    • 11:05am to 11:30am
    • Traditional Medications (Biguanides, SUs, TZDs, Alpha-Glucosidase Inhibitors)
    • Deborah J. Wexler, MD, MPH
    • 11:30am to 11:55am
    • Insulin Therapy in the Patient with Diabetes
    • Guillermo Umpierrez, MD, CDCES, FACE, MACP
    • 11:55am to 12:30pm
    • Q and A and Practical Recommendations
    • Deborah J. Wexler, MD, MPH and Guillermo E. Umpierrez, MD, CDCES, FACE, MACP
    • 12:30pm to 1:15pm
    • Break

    Pharmacological Management of Type 2 Diabetes: Newer Medications

    • 1:15pm to 1:45pm
    • SGLT-2 Inhibitors: An Update
    • Silvio E. Inzucchi, MD
    • 1:45pm to 2:15pm
    • GLP-1 Receptor Agonists: An Update
    • Juan Frias, MD
    • 2:15pm to 2:45pm
    • Mineralocorticoid Receptor Antagonists: Role in Diabetes Care
    • George L. Bakris, MD, FAHA, FASN
    • 2:45pm to 3:30pm
    • Q and A and Practical Recommendations
    • Silvio E. Inzucchi, MD and George L. Bakris, MD, FAHA, FASN
    • 3:30pm to 3:40pm
    • Closing Remarks